Evidence map›Paper›PMID 39716787›Full record

SynthesisCurrent Alzheimer research2024

Apathy Associated with Alzheimer's Disease.

Dan Wu, Bo Zhang, Yajuan Chang, Shuming Huang

Abstract readSystematic Review
In one paragraph

Synthesis in Current Alzheimer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dan WuInstitute of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Bo ZhangInstitute of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.ORCID 0009-0004-1271-9538
Yajuan ChangInstitute of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Shuming HuangInstitute of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.

Funding

Heilongjiang University of Chinese Medicine (No. 2019BJP02)National Natural Science Foundation of China (NSFC) (No. 81873108)
6 · The paper itself

Abstract

INTRODUCTION/

objectiveApathy is a multidimensional and complex disease that is the primary neuropsychiatric symptom among those diagnosed with Alzheimer's disease (AD). Yet, apathy in AD is sometimes underestimated.

methodsA systematic literature review was conducted using databases such as PubMed, Scopus, and Web of Science. The search utilized specific keywords related to apathy and Alzheimer's disease (e.g., "apathy," "Alzheimer's disease," "neuropsychiatric symptoms," "front-striatal circuitry"). The studies were selected based on pre-defined criteria, including publication date (within the last 10 years), peer-reviewed status, and relevance to neurobiological, neurochemical, and behavioral aspects of apathy in AD. The articles were screened through title and abstract reviews, followed by full-text evaluations to ensure they met the inclusion criteria, such as relevance to apathy in Alzheimer's patients, study design rigor, and methodological quality.

resultsSome research on the behavioral and neurobiological characteristics of apathy in AD points to the role of the front-striatal circuitry, particularly the anterior cingulate cortex (ACC). In addition, we reviewed the neurochemical, neuropsychological, and neuropathological characteristics believed to be associated with apathy symptoms.

conclusionThe findings indicate that understanding the intricate neurobiological underpinnings of apathy in AD is crucial for developing targeted interventions. Our analysis suggests that a multimodal approach, incorporating both pharmacological and personalized non-pharmacological strategies, could enhance therapeutic efficacy and improve patient outcomes. This highlights the need for future research to explore these combined treatment modalities and their potential to alleviate apathy in AD patients.

Indexed as

Alzheimer DiseaseApathyHumansAlzheimer’s diseaseanterior cingulate cortexapathybehaviorologyneuropsychiatrictherapeutic efficacy.

Identifiers

PMID39716787
PMCPMC12079319

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.